Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects

NCT02594254 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

135

Enrollment

INDUSTRY

Sponsor class

Conditions

Dental Caries

Interventions

DRUG: C16G2 Gel
OTHER: Placebo

Sponsor

Armata Pharmaceuticals, Inc.

Collaborators

[object Object]
[object Object]
[object Object]